Antimullerian hormone levels decrease in female to male transsexual women using testosterone as cross sex therapy

Wednesday, April 29, 2015
Polycystic ovary syndrome is associated with elevated antimullerian hormone (AMH) levels. In this study, AMH serum levels significantly decreased after androgenic treatment in female-to-male transsexual subjects.

Read More

Translate »